EUVIMEDEUVIMED entdecken
Open Access

Seroprevalence and Factors Associated with Infection with Toxoplasma gondii in Iquitos and Lima, Peru

Carlos Alonso Flores B, Cusi Ferradas, Edith S Málaga-Machaca, Andrea Diestra, Hannah E Steinberg, Jaeson Calla, Guillermo Salvatierra, Catherine Apaza, Juan Jiménez, Natalie M Bowman, Robert H Gilman, Maritza Calderón

The American Journal of Tropical Medicine and Hygiene · 03.09.2025 · 113 (3) · 600-606

DOI: 10.4269/ajtmh.25-0135 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, erschienen am 03.09.2025. Verfasst von Carlos Alonso Flores B und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Enfermedades Infecciosas, Laboratorios de Investigación y Desarrollo, Universidad Peruana Cayetano Heredia, Lima, Peru. Hauptthemen laut MEDLINE: Toxoplasmosis, Toxoplasma, Antibodies, Protozoan, HIV Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: FIC NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Toxoplasma gondii infection can pose a significant health risk, particularly among immunocompromised individuals, such as people living with HIV (PLHIV). This study aimed to evaluate the seroprevalence of T. gondii and associated factors among PLHIV and individuals who are HIV negative in two distinct regions of Peru: Iquitos and Lima. We conducted a cross-sectional study, enrolling 281 participants (100 PLHIV and 181 HIV-negative participants). An in-house ELISA was used to detect IgG antibodies against T. gondii after ensuring that its performance was comparable with the commercially available Vircell ELISA kit. Our in-house ELISA demonstrated high reliability, with a positive agreement of 98.3% and a negative agreement of 100% with the Vircell ELISA kit. The overall seroprevalence of T. gondii was 62.3%, with significantly higher rates observed in Iquitos (88.0%) than in Lima (29.3%). People living with HIV showed a notably higher prevalence ratio (PR) for T. gondii seropositivity in both cities, with PRs of 1.18 (95% CI, 1.07–1.29) in Iquitos and 2.29 (95% CI, 1.30–4.05) in Lima. This study highlights the significant regional disparities in T. gondii seroprevalence between Iquitos and Lima, which may be driven by environmental and socioeconomic factors. Our findings underscore the need for region-specific public health interventions to mitigate the impact of T. gondii infections in PLHIV in Peru. Enhanced public health strategies, including improved access to clean water and sanitation in high-risk areas like Iquitos, may be important to reduce the burden of T. gondii and prevent severe complications in vulnerable populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ToxoplasmosisToxoplasmaAntibodies, ProtozoanHIV InfectionsHumansPeruSeroepidemiologic StudiesFemaleMaleAdultCross-Sectional StudiesMiddle AgedYoung AdultRisk FactorsImmunoglobulin GEnzyme-Linked Immunosorbent AssayAdolescentPrevalence

Substanzen

Antibodies, ProtozoanImmunoglobulin G

Autor:innen und Institutionen

  • Laboratorio de Enfermedades Infecciosas, Laboratorios de Investigación y Desarrollo, Universidad Peruana Cayetano Heredia, Lima, Peru.
  • Unidad de Investigación en Enfermedades Emergentes y Cambio Climático, Facultad de Salud Pública, Universidad Peruana Cayetano Heredia, Lima, Peru.
  • Department of Microbiology and Immunology, University of Illinois, Chicago, Illinois.
  • Facultad de Medicina, Programa de Doctorado en Ciencias de la Salud, Universidad Nacional Mayor de San Marcos, Lima, Peru.
  • School of Veterinary Medicine, Health Sciences Faculty, Universidad Peruana de Ciencias Aplicadas, Lima, Peru.
  • Laboratorio de Parasitología Molecular y Celular, Facultad de Ciencias Biológicas, Universidad Nacional Mayor de San Marcos, Lima, Peru.

Förderung

  • FIC NIH HHS
  • NIAID NIH HHS

Zitieren

APA

Flores B, C. A., Ferradas, C., Málaga-Machaca, E. S., Diestra, A., Steinberg, H. E., Calla, J., Salvatierra, G., Apaza, C., Jiménez, J., Bowman, N. M., Gilman, R. H., & Calderón, M. (2025). Seroprevalence and Factors Associated with Infection with Toxoplasma gondii in Iquitos and Lima, Peru. The American Journal of Tropical Medicine and Hygiene, 113(3), 600-606. https://doi.org/10.4269/ajtmh.25-0135

Vancouver

Flores B CA, Ferradas C, Málaga-Machaca ES, Diestra A, Steinberg HE, Calla J, et al. Seroprevalence and Factors Associated with Infection with Toxoplasma gondii in Iquitos and Lima, Peru. The American Journal of Tropical Medicine and Hygiene. 2025;113(3):600-606. doi:10.4269/ajtmh.25-0135

BibTeX
@article{FloresB2025,
  author = {Flores B, Carlos Alonso and Ferradas, Cusi and Málaga-Machaca, Edith S and Diestra, Andrea and Steinberg, Hannah E and Calla, Jaeson and Salvatierra, Guillermo and Apaza, Catherine and Jiménez, Juan and Bowman, Natalie M and Gilman, Robert H and Calderón, Maritza},
  title = {Seroprevalence and Factors Associated with Infection with Toxoplasma gondii in Iquitos and Lima, Peru},
  journal = {The American Journal of Tropical Medicine and Hygiene},
  year = {2025},
  volume = {113},
  number = {3},
  pages = {600--606},
  doi = {10.4269/ajtmh.25-0135}
}
Kostenlos starten →